6 minute read
Jan. 16, 2024
JNT-517: A First-In-Class Amino Acid Import Inhibitor from Reactive Affinity Probe Screening with Potential to Treat PKU
JNT-517
oral allosteric SLCA6A19 inhibitor Ph. Ib for PKU from RAPID screen for cryptic allosteric modulators First Disclosures, ACS Fall 2023 Jnana Therapeutics, Boston, MA
Loading...
